Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) was the target of a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 3,510,000 shares, an increase of 16.2% from the January 15th total of 3,020,000 shares. Based on an average daily volume of 1,070,000 shares, the days-to-cover ratio is presently 3.3 days.
Wall Street Analysts Forecast Growth
SNPS has been the subject of several research reports. Mizuho assumed coverage on Synopsys in a research report on Tuesday, October 22nd. They issued an “outperform” rating and a $650.00 target price for the company. Robert W. Baird dropped their price objective on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Needham & Company LLC reiterated a “buy” rating and set a $640.00 target price on shares of Synopsys in a report on Thursday, December 5th. Rosenblatt Securities restated a “buy” rating and issued a $635.00 price target on shares of Synopsys in a research note on Wednesday, December 4th. Finally, Redburn Atlantic began coverage on Synopsys in a research report on Monday, January 13th. They set a “buy” rating and a $600.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $641.82.
View Our Latest Stock Report on SNPS
Insider Transactions at Synopsys
Institutional Investors Weigh In On Synopsys
Institutional investors and hedge funds have recently bought and sold shares of the stock. Kieckhefer Group LLC purchased a new stake in Synopsys during the 4th quarter valued at approximately $27,000. Whipplewood Advisors LLC purchased a new position in Synopsys in the 4th quarter valued at approximately $33,000. Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Synopsys during the 4th quarter worth $34,000. Hazlett Burt & Watson Inc. lifted its holdings in shares of Synopsys by 40.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock valued at $35,000 after purchasing an additional 20 shares in the last quarter. Finally, Sierra Ocean LLC purchased a new stake in shares of Synopsys in the fourth quarter valued at $39,000. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Price Performance
Shares of Synopsys stock traded down $5.76 during trading on Monday, hitting $522.53. 943,680 shares of the stock were exchanged, compared to its average volume of 1,012,953. The firm’s 50-day moving average price is $510.78 and its 200 day moving average price is $517.72. The stock has a market cap of $80.77 billion, a price-to-earnings ratio of 35.99, a price-to-earnings-growth ratio of 3.49 and a beta of 1.12. Synopsys has a 12-month low of $457.52 and a 12-month high of $629.38.
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Read More
- Five stocks we like better than Synopsys
- How to Evaluate a Stock Before Buying
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- Stock Market Upgrades: What Are They?
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- How to Calculate Stock Profit
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.